Ling-Hong Liu (Linghong Liu)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Cell death & disease

Stem cell research & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Na Dong, Hui-Xian Ma, Xue-Qin Liu, Dong Li, Ling-Hong Liu, Qing Shi, Xiu-Li Ju
Histidine re-sensitizes pediatric acute lymphoblastic leukemia to 6-mercaptopurine through tetrahydrofolate consumption and SIRT5-mediated desuccinylation. Cell death & disease 15 (3) (2024)
Na Dong, Hui-Xian Ma, Xue-Qin Liu, Dong Li, Ling-Hong Liu, Qing Shi, Xiu-Li Ju
Histidine re-sensitizes pediatric acute lymphoblastic leukemia to 6-mercaptopurine through tetrahydrofolate consumption and SIRT5-mediated desuccinylation. Cell death & disease 15 (3) (2024)
Na Dong, Hui-Xian Ma, Xue-Qin Liu, Dong Li, Ling-Hong Liu, Qing Shi, Xiu-Li Ju
Histidine re-sensitizes pediatric acute lymphoblastic leukemia to 6-mercaptopurine through tetrahydrofolate consumption and SIRT5-mediated desuccinylation. Cell death & disease 15 (3) (2024)
Qingxi Qu, Ling-Hong Liu, Yuqian Cui, Hongli Liu, Jingyang Yi, Weidong Bing, Chunxiao Liu, Detian Jiang, Yanwen Bi
miR-126-3p containing exosomes derived from human umbilical cord mesenchymal stem cells promote angiogenesis and attenuate ovarian granulosa cell apoptosis in a preclinical rat model of premature ovarian failure. Stem cell research & therapy 13 (1) (2022)
Qingxi Qu, Limei Wang, Weidong Bing, Yanwen Bi, Chunmei Zhang, Xuanxuan Jing, Ling-Hong Liu
miRNA-126-3p carried by human umbilical cord mesenchymal stem cell enhances endothelial function through exosome-mediated mechanisms in vitro and attenuates vein graft neointimal formation in vivo. Stem cell research & therapy 11 (1) (2020)